Literature DB >> 23603657

The predicted relative risk of premature ovarian failure for three radiotherapy modalities in a girl receiving craniospinal irradiation.

A Pérez-Andújar1, W D Newhauser, P J Taddei, A Mahajan, R M Howell.   

Abstract

In girls and young women, irradiation of the ovaries can reduce the number of viable ovarian primordial follicles, which may lead to premature ovarian failure (POF) and subsequently to sterility. One strategy to minimize this late effect is to reduce the radiation dose to the ovaries. A primary means of reducing dose is to choose a radiotherapy technique that avoids irradiating nearby normal tissue; however, the relative risk of POF (RRPOF) due to the various therapeutic options has not been assessed. This study compared the predicted RRPOF after craniospinal proton radiotherapy, conventional photon radiotherapy (CRT) and intensity-modulated photon radiotherapy (IMRT). We calculated the equivalent dose delivered to the ovaries of an 11-year-old girl from therapeutic and stray radiation. We then predicted the percentage of ovarian primordial follicles killed by radiation and used this as a measure of the RRPOF; we also calculated the ratio of the relative risk of POF (RRRPOF) among the three radiotherapies. Proton radiotherapy had a lower RRPOF than either of the other two types. We also tested the sensitivity of the RRRPOF between photon and proton therapies to the anatomic position of the ovaries, i.e., proximity to the treatment field (2 ≤ RRRPOF ≤ 10). We found that CRT and IMRT have higher risks of POF than passive-scattering proton radiotherapy (PRT) does, regardless of uncertainties in the ovarian location. Overall, PRT represents a lower RRPOF over the two other modalities.

Entities:  

Mesh:

Year:  2013        PMID: 23603657      PMCID: PMC3875375          DOI: 10.1088/0031-9155/58/10/3107

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  32 in total

1.  Relative biological effectiveness (RBE), quality factor (Q), and radiation weighting factor (w(R)). A report of the International Commission on Radiological Protection.

Authors: 
Journal:  Ann ICRP       Date:  2003

2.  Field-in-field technique with intrafractionally modulated junction shifts for craniospinal irradiation.

Authors:  Sue S Yom; Erik K Frija; Anita Mahajan; Eric Chang; Kelli Klein; Almon Shiu; Jared Ohrt; Shiao Woo
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-15       Impact factor: 7.038

3.  Intensity-modulated radiotherapy for craniospinal irradiation: target volume considerations, dose constraints, and competing risks.

Authors:  William Parker; Edith Filion; David Roberge; Carolyn R Freeman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-01       Impact factor: 7.038

4.  Laparoscopic ovarian transposition.

Authors:  A L Covens; H W van der Putten; A W Fyles; P M Leung; P F O'Brien; K J Murphy; A D DePetrillo
Journal:  Eur J Gynaecol Oncol       Date:  1996       Impact factor: 0.196

5.  Predicting age of ovarian failure after radiation to a field that includes the ovaries.

Authors:  W Hamish B Wallace; Angela B Thomson; Frank Saran; Tom W Kelsey
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-07-01       Impact factor: 7.038

6.  Prognostic factors and secondary malignancies in childhood medulloblastoma.

Authors:  T Stavrou; C M Bromley; H S Nicholson; J Byrne; R J Packer; A M Goldstein; G H Reaman
Journal:  J Pediatr Hematol Oncol       Date:  2001-10       Impact factor: 1.289

7.  American Society of Clinical Oncology recommendations on fertility preservation in cancer patients.

Authors:  Stephanie J Lee; Leslie R Schover; Ann H Partridge; Pasquale Patrizio; W Hamish Wallace; Karen Hagerty; Lindsay N Beck; Lawrence V Brennan; Kutluk Oktay
Journal:  J Clin Oncol       Date:  2006-05-01       Impact factor: 44.544

Review 8.  Preserving fertility in prepubertal children.

Authors:  F Sauvat; N Binart; C Poirot; S Sarnacki
Journal:  Horm Res       Date:  2009-01-21

9.  The radiosensitivity of the human oocyte.

Authors:  W H B Wallace; A B Thomson; T W Kelsey
Journal:  Hum Reprod       Date:  2003-01       Impact factor: 6.918

10.  Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams.

Authors:  Phillip J Taddei; Dragan Mirkovic; Jonas D Fontenot; Annelise Giebeler; Yuanshui Zheng; David Kornguth; Radhe Mohan; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2009-03-20       Impact factor: 3.609

View more
  19 in total

1.  A simple and fast physics-based analytical method to calculate therapeutic and stray doses from external beam, megavoltage x-ray therapy.

Authors:  Lydia J Jagetic; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2015-06-04       Impact factor: 3.609

2.  A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation.

Authors:  Rui Zhang; Rebecca M Howell; Phillip J Taddei; Annelise Giebeler; Anita Mahajan; Wayne D Newhauser
Journal:  Radiother Oncol       Date:  2014-08-12       Impact factor: 6.280

Review 3.  Proton therapy for the treatment of children with CNS malignancies.

Authors:  Radhika Sreeraman; Daniel J Indelicato
Journal:  CNS Oncol       Date:  2014-03

4.  Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma.

Authors:  Bree R Eaton; Natia Esiashvili; Sungjin Kim; Briana Patterson; Elizabeth A Weyman; Lauren T Thornton; Claire Mazewski; Tobey J MacDonald; David Ebb; Shannon M MacDonald; Nancy J Tarbell; Torunn I Yock
Journal:  Neuro Oncol       Date:  2015-12-19       Impact factor: 12.300

Review 5.  The physics of proton therapy.

Authors:  Wayne D Newhauser; Rui Zhang
Journal:  Phys Med Biol       Date:  2015-03-24       Impact factor: 3.609

6.  Low- and middle-income countries can reduce risks of subsequent neoplasms by referring pediatric craniospinal cases to centralized proton treatment centers.

Authors:  Phillip J Taddei; Nabil Khater; Bassem Youssef; Rebecca M Howell; Wassim Jalbout; Rui Zhang; Fady B Geara; Annelise Giebeler; Anita Mahajan; Dragan Mirkovic; Wayne D Newhauser
Journal:  Biomed Phys Eng Express       Date:  2018-02-07

7.  Risk-optimized proton therapy to minimize radiogenic second cancers.

Authors:  Laura A Rechner; John G Eley; Rebecca M Howell; Rui Zhang; Dragan Mirkovic; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2015-04-28       Impact factor: 3.609

8.  Analytical model for out-of-field dose in photon craniospinal irradiation.

Authors:  Phillip J Taddei; Wassim Jalbout; Rebecca M Howell; Nabil Khater; Fady Geara; Kenneth Homann; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2013-10-08       Impact factor: 3.609

9.  Preserving Fertility in Adolescent Girls and Young Women Requiring Craniospinal Irradiation: A Case Report and Discussion of Options to Be Considered Prior to Treatment.

Authors:  Nataniel H Lester-Coll; Christopher B Morse; Huifang A Zhai; Stefan Both; Jill P Ginsberg; Clarisa R Gracia; Robert A Lustig; Zelig Tochner; Christine E Hill-Kayser
Journal:  J Adolesc Young Adult Oncol       Date:  2014-06-01       Impact factor: 2.223

10.  Craniospinal irradiation prior to stem cell transplant for hematologic malignancies with CNS involvement: Effectiveness and toxicity after photon or proton treatment.

Authors:  Jillian R Gunther; Ahmad R Rahman; Wenli Dong; Zeinab Abou Yehia; Partow Kebriaei; Gabriela Rondon; Chelsea C Pinnix; Sarah A Milgrom; Pamela K Allen; Bouthaina S Dabaja; Grace L Smith
Journal:  Pract Radiat Oncol       Date:  2017-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.